Laura Libonati

Pubblicazioni

Titolo Pubblicato in Anno
Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy JOURNAL OF THE NEUROLOGICAL SCIENCES 2024
MiR206 and 423‑3p Are Differently Modulated in Fast and Slow‑Progressing Amyotrophic Lateral Sclerosis Patients NEUROMOLECULAR MEDICINE 2024
Emotion recognition in amyotrophic lateral sclerosis in a dynamic environment JOURNAL OF THE NEUROLOGICAL SCIENCES 2024
Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study ANTIOXIDANTS 2024
GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosis BRAIN, BEHAVIOR, AND IMMUNITY 2024
Retrospective observational study on the use of acetyl-L-carnitine in ALS JOURNAL OF NEUROLOGY 2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases CURRENT NEUROPHARMACOLOGY 2023
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey NEUROLOGICAL SCIENCES 2023
Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication JOURNAL OF NEUROLOGY 2023
A novel homozygous mutation in TBK1 gene causing ALS-FTD NEUROLOGICAL SCIENCES 2022
Classical and Unexpected Effects of Ultra-Micronized {PEA} in Neuromuscular Function BIOMOLECULES 2022
Effects of Skin Stimulation on Sensory-Motor Networks Excitability: Possible Implications for Physical Training in Amyotrophic Lateral Sclerosis FRONTIERS IN NEUROLOGY 2022
The Silent Period for Small Fiber Sensory Neuropathy Assessment in a Mixed Cohort of Transthyretin-Mediated Amyloidosis BIOMEDICINES 2022
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study FRONTIERS IN PHARMACOLOGY 2022
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients NEUROLOGICAL SCIENCES 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial EUROPEAN JOURNAL OF NEUROLOGY 2022
A case of acute motor and sensory axonal neuropathy mimicking brain death NEUROLOGICAL SCIENCES 2021
PREVALENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN LATIUM REGION (ITALY) BRAIN AND BEHAVIOR 2021
Creatine kinase and progression rate in amyotrophic lateral sclerosis CELLS 2020
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment. CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma